Ergoteles’s Alignment Healthcare ALHC Stock Holding History

Ergoteles’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,700	Closed	-$113K	–	62
2023 Q2	$113K	Buy	+19,700	New	+$127K	0.01%	910

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ergoteles's ALHC Position: Q3 2023 in Review

Ergoteles sold out of Alignment Healthcare (ALHC) in Q3 2023, closing a stake of 19,700 shares — an estimated $113K sold.

Ergoteles first reported a position in ALHC in Q2 2023 and held it in 1 quarter. The position peaked at $113K in Q2 2023. 131 funds tracked by Wall St. Rank hold ALHC as of Q3 2023.

Ergoteles reported no remaining Alignment Healthcare position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 19,700 Alignment Healthcare shares in Q3 2023, an estimated $113K.
Ergoteles first reported a position in Alignment Healthcare in Q2 2023 and held it in 1 quarter.
Ergoteles's Alignment Healthcare position peaked at $113K in Q2 2023.
131 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.